Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black women
Purpose: Human papillomavirus (HPV) is the causative agent of cervical cancer. Black women are disproportionally diagnosed and have higher mortality from cervical cancer in the United States. Here we describe the prophylactic efficacy and safety of a quadrivalent HPV-6/11/16/18 vaccine in black wome...
Autores Principales: | , , , , , , , , , , |
---|---|
Formato: | Artículo (Article) |
Lenguaje: | Inglés (English) |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://repository.urosario.edu.co/handle/10336/22218 https://doi.org/10.1016/j.jadohealth.2012.07.003 |